Less Ads, More Data, More Tools Register for FREE

Pin to quick picksUnicorn Asset Management Regulatory News (UAV)

Share Price Information for Unicorn Asset Management (UAV)

Share Price is delayed by 15 minutes
Get Live Data
70.00    0.00 (0.00%)
Bid:
67.00
Ask:
73.00
Spread: 6.00 (8.955%)
Market Cap: £180.27m
UAV Live PriceLast checked at - London Stock Exchange

Intraday Unicorn Asset Management Share Chart

Interim Management Statement

25 Jul 2012 10:00

Unicorn AIM VCT plc

Interim Management Statement

For the period from 31 March 2012 to 30 June 2012

Introduction

The Company has prepared this Interim Management Statement (IMS) in accordance with the Disclosure and Transparency Rules of the UK Listing Authority. The IMS covers the three month period ended 30 June 2012, together with relevant information up to the date of publication.

Investment Objective

The objective of the Company is to provide Shareholders with an attractive return from a diversified portfolio of investments, predominantly in the shares of AIM quoted companies, by maximising the stream of dividend distributions to Shareholders from the income and capital gains generated by the portfolio.

It is also the objective that the Company should continue to qualify as a

Venture Capital Trust, so that Shareholders benefit from the taxation advantages that this brings. To achieve this at least 70% of the Company's total assets are to be invested in qualifying investments of which 30% by value must be in ordinary shares carrying no preferential rights to dividends or return of capital and no rights to redemption.

Performance

UK equity indices registered declines in the three month period ended 30 June 2012. The FTSE All-Share Index (excluding investment trusts) was down 2.6% on a total return basis, the FTSE AIM All-Share Index on a similar basis fell by 14.8%, whilst the Numis Smaller Companies Index declined by 5.6%.

The Company outperformed during the period with Net Asset Value (NAV) increasing by 1.7%. NAV performance is calculated on a total return basis, after adding back dividends paid. No dividends were paid in the period.

As at 30 June 2012, the unaudited NAV was 99.1 pence per share, compared to an unaudited NAV of 97.4 pence per share as at 31 March 2012.

Material Transactions

There were a small number of material transactions during the period under review.

In the Company's qualifying portfolio, partial disposals were made in Abcam and Animalcare in order to maintain appropriate weightings following strong share price performance.

The qualifying holding in Prologic was sold in full after a recommended cash offer for the business was announced at the end of March 2012.

In the non-qualifying portfolio, a partial disposal was made in the Unicorn UK Smaller Companies Fund.

Net proceeds from these disposals amounted to just under £1.2m and the aggregate capital gain was £48,000.

There were no new investments and no other material transactions in the period under review.

Top 10 Equity Holdings at 30 June 2012, as a percentage (%) of the Fund

Abcam 16.0%

Unicorn UK Smaller Companies Fund 7.8%

Tracsis 3.6%Anpario 3.5%Mears Group 3.5%IDOX 3.5%Mattioli Woods 3.0%Unicorn Mastertrust Fund 3.0%Surgical Innovations 2.9%Animalcare Group 2.7%Total 49.5%Material Events

In the three month period ended 30 June 2012, a total of 87,149 Ordinary Shares were purchased for cancellation at an average price of 66.0 pence per share.

After the period end, a further 124,075 shares were purchased for cancellation at a price of 71 pence per share.

There were no other material events during the period under review.

Date   Source Headline
4th Aug 201710:32 amRNSNet Asset Value(s)
25th Jul 20175:09 pmRNSOffer for Subscription and Issue of Prospectus
13th Jul 201712:17 pmRNSIntention to launch an Offer
5th Jul 20172:46 pmRNSNet Asset Value(s)
3rd Jul 201712:01 pmRNSTotal Voting Rights
9th Jun 20175:08 pmRNSTransaction in Own Shares
6th Jun 201712:19 pmRNSNet Asset Value(s)
1st Jun 201711:00 amRNSTotal Voting Rights
31st May 20177:00 amRNSHalf-year Report
10th May 20175:09 pmRNSTransaction in Own Shares
9th May 20175:15 pmRNSClosed Period Notification
5th May 201711:30 amRNSNet Asset Value(s)
2nd May 201710:28 amRNSTotal Voting Rights
7th Apr 20174:52 pmRNSTransaction in Own Shares
6th Apr 20172:54 pmRNSNet Asset Value(s)
3rd Apr 201710:58 amRNSTotal Voting Rights
8th Mar 20175:17 pmRNSTransaction in Own Shares
6th Mar 201710:18 amRNSNet Asset Value(s)
1st Mar 201710:31 amRNSTotal Voting Rights
16th Feb 20174:43 pmRNSTransaction in Own Shares
15th Feb 20175:44 pmRNSTransaction in Own Shares
10th Feb 20175:45 pmRNSDirector/PDMR Shareholding
9th Feb 20173:32 pmRNSTotal Voting Rights
8th Feb 20175:38 pmRNSIssue of Equity
6th Feb 20171:22 pmRNSNet Asset Value(s)
3rd Feb 20175:25 pmRNSOffer for Subscription - Update
19th Jan 201711:21 amRNSOffer for Subscription and Issue of Prospectus
16th Jan 201712:26 pmRNSVoluntary Interim Management Statement
12th Jan 20174:20 pmRNSResult of AGM
5th Jan 20175:44 pmRNSNet Asset Value(s)
3rd Jan 20174:17 pmRNSTotal Voting Rights
13th Dec 20164:47 pmRNSTransaction in Own Shares
6th Dec 20164:04 pmRNSNet Asset Value(s)
1st Dec 20164:31 pmRNSTotal Voting Rights
30th Nov 20163:35 pmRNSIntention to launch an Offer
24th Nov 20167:00 amRNSAnnual Financial Report
9th Nov 20165:15 pmRNSTransaction in Own Shares
8th Nov 201610:19 amRNSClosed Period Notification
4th Nov 20164:28 pmRNSNet Asset Value(s)
1st Nov 20169:57 amRNSTotal Voting Rights
13th Oct 20165:32 pmRNSTransaction in Own Shares
11th Oct 20167:00 amRNSNet Asset Value(s)
3rd Oct 20165:27 pmRNSTotal Voting Rights
7th Sep 20165:00 pmRNSTransaction in Own Shares
6th Sep 20163:10 pmRNSNet Asset Value(s)
5th Aug 201611:01 amRNSNet Asset Value(s)
1st Aug 201610:28 amRNSTotal Voting Rights
19th Jul 20168:48 amRNSVoluntary Interim Management Statement
15th Jul 201610:00 amRNSDirectorate Change
6th Jul 20164:32 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.